Industry Research Reports

Home > Reports > Medical Devices & Consumables > Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 92 Pages

Report ld: 3484190

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Artificial Blood Cells was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Artificial Blood Cells, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Blood Cells by region & country, by Type, and by Application.

The Artificial Blood Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Cells.

MARKET SEGMENTATION

By Company

Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others

Segment by Application

Cardiovascular Diseases
Anemia
Organ Transplant
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Artificial Blood Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Artificial Blood Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Artificial Blood Cells in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Artificial Blood Cells Product Introduction

1.2 Global Artificial Blood Cells Market Size Forecast

1.2.1 Global Artificial Blood Cells Sales Value (2020-2031)

1.2.2 Global Artificial Blood Cells Sales Volume (2020-2031)

1.2.3 Global Artificial Blood Cells Sales Price (2020-2031)

1.3 Artificial Blood Cells Market Trends & Drivers

1.3.1 Artificial Blood Cells Industry Trends

1.3.2 Artificial Blood Cells Market Drivers & Opportunity

1.3.3 Artificial Blood Cells Market Challenges

1.3.4 Artificial Blood Cells Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Artificial Blood Cells Players Revenue Ranking (2024)

2.2 Global Artificial Blood Cells Revenue by Company (2020-2025)

2.3 Global Artificial Blood Cells Players Sales Volume Ranking (2024)

2.4 Global Artificial Blood Cells Sales Volume by Company Players (2020-2025)

2.5 Global Artificial Blood Cells Average Price by Company (2020-2025)

2.6 Key Manufacturers Artificial Blood Cells Manufacturing Base and Headquarters

2.7 Key Manufacturers Artificial Blood Cells Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Artificial Blood Cells

2.9 Artificial Blood Cells Market Competitive Analysis

2.9.1 Artificial Blood Cells Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Blood Cells Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Animal Hemoglobin

3.1.2 Human Hemoglobin

3.1.3 Stem Cell

3.1.4 Others

3.2 Global Artificial Blood Cells Sales Value by Type

3.2.1 Global Artificial Blood Cells Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Artificial Blood Cells Sales Value, by Type (2020-2031)

3.2.3 Global Artificial Blood Cells Sales Value, by Type (%) (2020-2031)

3.3 Global Artificial Blood Cells Sales Volume by Type

3.3.1 Global Artificial Blood Cells Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Artificial Blood Cells Sales Volume, by Type (2020-2031)

3.3.3 Global Artificial Blood Cells Sales Volume, by Type (%) (2020-2031)

3.4 Global Artificial Blood Cells Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cardiovascular Diseases

4.1.2 Anemia

4.1.3 Organ Transplant

4.1.4 Others

4.2 Global Artificial Blood Cells Sales Value by Application

4.2.1 Global Artificial Blood Cells Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Artificial Blood Cells Sales Value, by Application (2020-2031)

4.2.3 Global Artificial Blood Cells Sales Value, by Application (%) (2020-2031)

4.3 Global Artificial Blood Cells Sales Volume by Application

4.3.1 Global Artificial Blood Cells Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Artificial Blood Cells Sales Volume, by Application (2020-2031)

4.3.3 Global Artificial Blood Cells Sales Volume, by Application (%) (2020-2031)

4.4 Global Artificial Blood Cells Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Artificial Blood Cells Sales Value by Region

5.1.1 Global Artificial Blood Cells Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Artificial Blood Cells Sales Value by Region (2020-2025)

5.1.3 Global Artificial Blood Cells Sales Value by Region (2026-2031)

5.1.4 Global Artificial Blood Cells Sales Value by Region (%), (2020-2031)

5.2 Global Artificial Blood Cells Sales Volume by Region

5.2.1 Global Artificial Blood Cells Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Artificial Blood Cells Sales Volume by Region (2020-2025)

5.2.3 Global Artificial Blood Cells Sales Volume by Region (2026-2031)

5.2.4 Global Artificial Blood Cells Sales Volume by Region (%), (2020-2031)

5.3 Global Artificial Blood Cells Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Artificial Blood Cells Sales Value, 2020-2031

5.4.2 North America Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Artificial Blood Cells Sales Value, 2020-2031

5.5.2 Europe Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Artificial Blood Cells Sales Value, 2020-2031

5.6.2 Asia Pacific Artificial Blood Cells Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Artificial Blood Cells Sales Value, 2020-2031

5.7.2 South America Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Artificial Blood Cells Sales Value, 2020-2031

5.8.2 Middle East & Africa Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Artificial Blood Cells Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Artificial Blood Cells Sales Value

6.2.1 Key Countries/Regions Artificial Blood Cells Sales Value, 2020-2031

6.2.2 Key Countries/Regions Artificial Blood Cells Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Artificial Blood Cells Sales Value, 2020-2031

6.3.2 United States Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Artificial Blood Cells Sales Value, 2020-2031

6.4.2 Europe Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Artificial Blood Cells Sales Value, 2020-2031

6.5.2 China Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.5.3 China Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Artificial Blood Cells Sales Value, 2020-2031

6.6.2 Japan Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Artificial Blood Cells Sales Value, 2020-2031

6.7.2 South Korea Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Artificial Blood Cells Sales Value, 2020-2031

6.8.2 Southeast Asia Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Artificial Blood Cells Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Artificial Blood Cells Sales Value, 2020-2031

6.9.2 India Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

6.9.3 India Artificial Blood Cells Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Dextro-Sang Corporation

7.1.1 Dextro-Sang Corporation Company Information

7.1.2 Dextro-Sang Corporation Introduction and Business Overview

7.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Dextro-Sang Corporation Artificial Blood Cells Product Offerings

7.1.5 Dextro-Sang Corporation Recent Development

7.2 BioPure Corporation

7.2.1 BioPure Corporation Company Information

7.2.2 BioPure Corporation Introduction and Business Overview

7.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 BioPure Corporation Artificial Blood Cells Product Offerings

7.2.5 BioPure Corporation Recent Development

7.3 Sangart

7.3.1 Sangart Company Information

7.3.2 Sangart Introduction and Business Overview

7.3.3 Sangart Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Sangart Artificial Blood Cells Product Offerings

7.3.5 Sangart Recent Development

7.4 Northfield Laboratories

7.4.1 Northfield Laboratories Company Information

7.4.2 Northfield Laboratories Introduction and Business Overview

7.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Northfield Laboratories Artificial Blood Cells Product Offerings

7.4.5 Northfield Laboratories Recent Development

7.5 Baxter International

7.5.1 Baxter International Company Information

7.5.2 Baxter International Introduction and Business Overview

7.5.3 Baxter International Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Baxter International Artificial Blood Cells Product Offerings

7.5.5 Baxter International Recent Development

7.6 Dentritech

7.6.1 Dentritech Company Information

7.6.2 Dentritech Introduction and Business Overview

7.6.3 Dentritech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Dentritech Artificial Blood Cells Product Offerings

7.6.5 Dentritech Recent Development

7.7 FluorO2 Therapeutics

7.7.1 FluorO2 Therapeutics Company Information

7.7.2 FluorO2 Therapeutics Introduction and Business Overview

7.7.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 FluorO2 Therapeutics Artificial Blood Cells Product Offerings

7.7.5 FluorO2 Therapeutics Recent Development

7.8 Nuvox Pharma

7.8.1 Nuvox Pharma Company Information

7.8.2 Nuvox Pharma Introduction and Business Overview

7.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Nuvox Pharma Artificial Blood Cells Product Offerings

7.8.5 Nuvox Pharma Recent Development

7.9 Alpha Therapeutic Corporation

7.9.1 Alpha Therapeutic Corporation Company Information

7.9.2 Alpha Therapeutic Corporation Introduction and Business Overview

7.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Product Offerings

7.9.5 Alpha Therapeutic Corporation Recent Development

7.10 HemoBioTech

7.10.1 HemoBioTech Company Information

7.10.2 HemoBioTech Introduction and Business Overview

7.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 HemoBioTech Artificial Blood Cells Product Offerings

7.10.5 HemoBioTech Recent Development

8 Industry Chain Analysis

8.1 Artificial Blood Cells Industrial Chain

8.2 Artificial Blood Cells Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Artificial Blood Cells Sales Model

8.5.2 Sales Channel

8.5.3 Artificial Blood Cells Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Artificial Blood Cells Market Trends

Table 2. Artificial Blood Cells Market Drivers & Opportunity

Table 3. Artificial Blood Cells Market Challenges

Table 4. Artificial Blood Cells Market Restraints

Table 5. Global Artificial Blood Cells Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Artificial Blood Cells Revenue Market Share by Company (2020-2025)

Table 7. Global Artificial Blood Cells Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Artificial Blood Cells Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Artificial Blood Cells Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Artificial Blood Cells Manufacturing Base and Headquarters

Table 11. Key Manufacturers Artificial Blood Cells Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Artificial Blood Cells

Table 13. Global Artificial Blood Cells Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Artificial Blood Cells Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Artificial Blood Cells Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Artificial Blood Cells Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Artificial Blood Cells Sales Market Share in Value by Type (2020-2025)

Table 20. Global Artificial Blood Cells Sales Market Share in Value by Type (2026-2031)

Table 21. Global Artificial Blood Cells Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Artificial Blood Cells Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Artificial Blood Cells Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Artificial Blood Cells Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Artificial Blood Cells Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Artificial Blood Cells Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Artificial Blood Cells Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Artificial Blood Cells Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Artificial Blood Cells Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Artificial Blood Cells Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Artificial Blood Cells Sales Market Share in Value by Application (2020-2025)

Table 32. Global Artificial Blood Cells Sales Market Share in Value by Application (2026-2031)

Table 33. Global Artificial Blood Cells Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Artificial Blood Cells Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Artificial Blood Cells Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Artificial Blood Cells Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Artificial Blood Cells Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Artificial Blood Cells Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Artificial Blood Cells Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Artificial Blood Cells Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Artificial Blood Cells Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Artificial Blood Cells Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Artificial Blood Cells Sales Value by Region (2020-2025) & (%)

Table 44. Global Artificial Blood Cells Sales Value by Region (2026-2031) & (%)

Table 45. Global Artificial Blood Cells Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Artificial Blood Cells Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Artificial Blood Cells Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Artificial Blood Cells Sales Volume by Region (2020-2025) & (%)

Table 49. Global Artificial Blood Cells Sales Volume by Region (2026-2031) & (%)

Table 50. Global Artificial Blood Cells Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Artificial Blood Cells Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Artificial Blood Cells Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Artificial Blood Cells Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Artificial Blood Cells Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Artificial Blood Cells Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Artificial Blood Cells Sales Volume, (2026-2031) & (K Units)

Table 57. Dextro-Sang Corporation Company Information

Table 58. Dextro-Sang Corporation Introduction and Business Overview

Table 59. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Dextro-Sang Corporation Artificial Blood Cells Product Offerings

Table 61. Dextro-Sang Corporation Recent Development

Table 62. BioPure Corporation Company Information

Table 63. BioPure Corporation Introduction and Business Overview

Table 64. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. BioPure Corporation Artificial Blood Cells Product Offerings

Table 66. BioPure Corporation Recent Development

Table 67. Sangart Company Information

Table 68. Sangart Introduction and Business Overview

Table 69. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Sangart Artificial Blood Cells Product Offerings

Table 71. Sangart Recent Development

Table 72. Northfield Laboratories Company Information

Table 73. Northfield Laboratories Introduction and Business Overview

Table 74. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Northfield Laboratories Artificial Blood Cells Product Offerings

Table 76. Northfield Laboratories Recent Development

Table 77. Baxter International Company Information

Table 78. Baxter International Introduction and Business Overview

Table 79. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Baxter International Artificial Blood Cells Product Offerings

Table 81. Baxter International Recent Development

Table 82. Dentritech Company Information

Table 83. Dentritech Introduction and Business Overview

Table 84. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Dentritech Artificial Blood Cells Product Offerings

Table 86. Dentritech Recent Development

Table 87. FluorO2 Therapeutics Company Information

Table 88. FluorO2 Therapeutics Introduction and Business Overview

Table 89. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. FluorO2 Therapeutics Artificial Blood Cells Product Offerings

Table 91. FluorO2 Therapeutics Recent Development

Table 92. Nuvox Pharma Company Information

Table 93. Nuvox Pharma Introduction and Business Overview

Table 94. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Nuvox Pharma Artificial Blood Cells Product Offerings

Table 96. Nuvox Pharma Recent Development

Table 97. Alpha Therapeutic Corporation Company Information

Table 98. Alpha Therapeutic Corporation Introduction and Business Overview

Table 99. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Alpha Therapeutic Corporation Artificial Blood Cells Product Offerings

Table 101. Alpha Therapeutic Corporation Recent Development

Table 102. HemoBioTech Company Information

Table 103. HemoBioTech Introduction and Business Overview

Table 104. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. HemoBioTech Artificial Blood Cells Product Offerings

Table 106. HemoBioTech Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Artificial Blood Cells Downstream Customers

Table 110. Artificial Blood Cells Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Artificial Blood Cells Product Picture

Figure 2. Global Artificial Blood Cells Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Artificial Blood Cells Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Artificial Blood Cells Sales Volume (2020-2031) & (K Units)

Figure 5. Global Artificial Blood Cells Sales Price (2020-2031) & (US$/Unit)

Figure 6. Artificial Blood Cells Report Years Considered

Figure 7. Global Artificial Blood Cells Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Artificial Blood Cells Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Artificial Blood Cells Revenue in 2024

Figure 10. Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Animal Hemoglobin Picture

Figure 12. Human Hemoglobin Picture

Figure 13. Stem Cell Picture

Figure 14. Others Picture

Figure 15. Global Artificial Blood Cells Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Artificial Blood Cells Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Artificial Blood Cells Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 18. Global Artificial Blood Cells Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Artificial Blood Cells Price by Type (2020-2031) & (US$/Unit)

Figure 20. Product Picture of Cardiovascular Diseases

Figure 21. Product Picture of Anemia

Figure 22. Product Picture of Organ Transplant

Figure 23. Product Picture of Others

Figure 24. Global Artificial Blood Cells Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 25. Global Artificial Blood Cells Sales Value Market Share by Application, 2024 & 2031

Figure 26. Global Artificial Blood Cells Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 27. Global Artificial Blood Cells Sales Volume Market Share by Application, 2024 & 2031

Figure 28. Global Artificial Blood Cells Price by Application (2020-2031) & (US$/Unit)

Figure 29. North America Artificial Blood Cells Sales Value (2020-2031) & (US$ Million)

Figure 30. North America Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

Figure 31. Europe Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

Figure 33. Asia Pacific Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Artificial Blood Cells Sales Value by Region (%), 2024 VS 2031

Figure 35. South America Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 36. South America Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

Figure 37. Middle East & Africa Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 38. Middle East & Africa Artificial Blood Cells Sales Value by Country (%), 2024 VS 2031

Figure 39. Key Countries/Regions Artificial Blood Cells Sales Value (%), (2020-2031)

Figure 40. Key Countries/Regions Artificial Blood Cells Sales Volume (%), (2020-2031)

Figure 41. United States Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 42. United States Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 43. United States Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 44. Europe Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 45. Europe Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 46. Europe Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 47. China Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 48. China Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 49. China Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 50. Japan Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 51. Japan Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 52. Japan Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 53. South Korea Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 54. South Korea Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 55. South Korea Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 56. Southeast Asia Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 57. Southeast Asia Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 58. Southeast Asia Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 59. India Artificial Blood Cells Sales Value, (2020-2031) & (US$ Million)

Figure 60. India Artificial Blood Cells Sales Value by Type (%), 2024 VS 2031

Figure 61. India Artificial Blood Cells Sales Value by Application (%), 2024 VS 2031

Figure 62. Artificial Blood Cells Industrial Chain

Figure 63. Artificial Blood Cells Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Artificial Blood Cells market? zhanKai

The top companies in the global Artificial Blood Cells market are Dextro-Sang Corporation、BioPure Corporation、Sangart.

Related Reports

Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 134
USD 3950.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2026
The global Artificial Blood Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 114
USD 2900.00
(Single User License)
Global Artificial Blood Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Blood Cells market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global Artificial Blood Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Blood Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 131
USD 4900.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2025
The global market for Artificial Blood Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 82
USD 2900.00
(Single User License)
Global Artificial Blood Cells Market Insights, Forecast to 2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Global Artificial Blood Cells Market Research Report 2024
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
Artificial Blood Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published Date: 2024-01-10
Pages: 128
USD 3950.00
(Single User License)

Artificial Blood Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Blood Cells was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 134
USD 3950.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2026
The global Artificial Blood Cells market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 114
USD 2900.00 (Single User License)
Global Artificial Blood Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Blood Cells market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)
Global Artificial Blood Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Artificial Blood Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 131
USD 4900.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2025
The global market for Artificial Blood Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 82
USD 2900.00 (Single User License)
Global Artificial Blood Cells Market Insights, Forecast to 2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published: 2024-04-12
Pages: 107
USD 4900.00 (Single User License)
Global Artificial Blood Cells Market Research Report 2024
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)
Artificial Blood Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
Published: 2024-01-10
Pages: 128
USD 3950.00 (Single User License)